期刊文献+

恩替卡韦治疗慢性重症乙型肝炎的临床疗效研究 被引量:1

下载PDF
导出
摘要 目的探究恩替卡韦治疗慢性重症乙型肝炎的临床疗效。方法 68例慢性重症乙型肝炎分为对照组和观察组,每组34例。对照组患者接受综合治疗,观察组患者则在综合治疗的基础上接受恩替卡韦治疗。比较两组肝功能指标及临床疗效。结果观察组白蛋白(ALB)高于对照组,谷丙转氨酶(ALT)及凝血酶原时间(PT)低于对照组(P<0.05)。观察组治疗总有效率(91.18%)明显优于对照组(64.71%)(P<0.05)。结论恩替卡韦治疗慢性重症乙型肝炎有利于改善患者的肝功能,提高治疗效果,值得推广。
作者 常冰
出处 《中国实用医药》 2016年第21期140-141,共2页 China Practical Medicine
  • 相关文献

参考文献4

二级参考文献22

  • 1OKAGAWA Y, TAKADA K, HISAIH, et al. Successful treatment with entecavir for reactivation of hepatitis B virus following sys- temic chemotherapy in a hepatitis B surface antigen-negative pa- tient with colorectal cancer[J]. Intern Med, 2014, 53(16): 1759- 1762.
  • 2OZARAS R, METE B, CEYLANB, et al. First-line monothera- pies of tenofovir and entecavir have comparable efficacies in hepatitis B treatment[J]. Eur J Gastroenterol Hepatol. 2014, 26 (7): 774-780.
  • 3SHOUVALD. The pros and cons of lamivudine vs. entecavir indecompensated or severe acute exacerbation of chronic hepatitis B[J]. J Hepatol, 2014, 60(6): 1108-1109.
  • 4TSAI WL, CHIANG PH, CHAN HH, et al. Early entecavir treatment for chronic hepatitis B with severe acute exacerbation [J]. Antimicrob Agents Chemother, 2014, 58(4): 1918-1921.
  • 5MIQUEL M, NUI~IEZ0, TRAPERO-MARUGANM, et al. Efficacy and safety of entecavir and/or tenofovir in hepatitis B compensat- ed and decompensated cirrhotic patients in clinical practice[J]. Ann Hepatol, 2013, 12(2): 205-212.
  • 6TANAKA H, SAKUMA I, HASHIMOTO S, et al. Hepatitis B reactivation in a multiple myeloma patient with resolved hepatitis B infection during bortezomib therapy : case report[J]. J Clin Exp Hematop, 2012, 52(1): 67-69.
  • 7AOUDJANE S, CHAPONDA M, GONZ?LEZ DEL CASTILLO AA, et al. Hepatitis B virus sub-genotype A1 infection is char- aeterized by high replication levels and rapid emergence of drug resistance in HIV-positive adults receiving first-line antiretroviral therapy in malawi[J]. Clin Infect Dis, 2014, 59(11): 1618-1626.
  • 8MCMAHON B J, BULKOW L, SIMONS B, et al. Relationship between level of hepatitis B virus DNA and liver disease: a population-based study of hepatitis B e antigen-negative persons with hepatitis B[J]. ClinGastroenterol Hepatol, 2014, 12(4): 701- 706.
  • 9李广明.探讨慢性乙型肝炎护肝治疗患者肝硬化发生率及相关危险因素[J].健康必读(中旬刊),2012,11(7):184--185.
  • 10胡肖兵,高洪波,李粤平,廖明儿.阿德福韦酯联合安络化纤丸抗肝纤维化疗效及组织学变化观察[J].中西医结合肝病杂志,2008,18(2):80-82. 被引量:17

共引文献36

同被引文献2

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部